Pilot Study of Treatment With Intravenous Enoxaparin and/or Oral Minocycline to Limit Infarct Size After Ischemic Stroke.

Trial Profile

Pilot Study of Treatment With Intravenous Enoxaparin and/or Oral Minocycline to Limit Infarct Size After Ischemic Stroke.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 May 2016

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Minocycline (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Apr 2011 Status changed from recruiting to discontinued, according to ClinicalTrials.Gov record.
    • 21 Apr 2009 Actual initiation date Apr 2009) added as reported by ClinicalTrials.gov.
    • 21 Apr 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top